Annual Total Expenses
$2.17 B
+$145.97 M+7.21%
31 December 2023
Summary:
Amneal Pharmaceuticals annual total expenses is currently $2.17 billion, with the most recent change of +$145.97 million (+7.21%) on 31 December 2023. During the last 3 years, it has risen by +$287.92 million (+15.30%). AMRX annual total expenses is now at all-time high.AMRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$625.99 M
+$7.16 M+1.16%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly total expenses is currently $625.99 million, with the most recent change of +$7.16 million (+1.16%) on 30 September 2024. Over the past year, it has increased by +$82.47 million (+15.17%). AMRX quarterly total expenses is now at all-time high.AMRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.2% | +15.2% |
| 3 y3 years | +15.3% | +32.6% |
| 5 y5 years | +56.6% | +46.1% |
AMRX Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +15.3% | at high | +32.6% |
| 5 y | 5 years | at high | +56.6% | at high | +51.1% |
| alltime | all time | at high | +191.5% | at high | +220.7% |
Amneal Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $625.99 M(+1.2%) |
| June 2024 | - | $618.84 M(+7.4%) |
| Mar 2024 | - | $575.96 M(-0.8%) |
| Dec 2023 | $2.17 B(+7.2%) | $580.81 M(+6.9%) |
| Sept 2023 | - | $543.53 M(+3.8%) |
| June 2023 | - | $523.63 M(+0.4%) |
| Mar 2023 | - | $521.39 M(-3.1%) |
| Dec 2022 | $2.02 B(+6.5%) | $538.33 M(+7.3%) |
| Sept 2022 | - | $501.72 M(-1.2%) |
| June 2022 | - | $508.04 M(+6.9%) |
| Mar 2022 | - | $475.29 M(-8.7%) |
| Dec 2021 | $1.90 B(+1.0%) | $520.73 M(+10.3%) |
| Sept 2021 | - | $472.03 M(+2.0%) |
| June 2021 | - | $462.96 M(+4.3%) |
| Mar 2021 | - | $444.03 M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $1.88 B(+6.6%) | $484.81 M(-6.0%) |
| Sept 2020 | - | $515.48 M(+14.4%) |
| June 2020 | - | $450.49 M(+4.6%) |
| Mar 2020 | - | $430.66 M(+4.0%) |
| Dec 2019 | $1.77 B(+27.5%) | $414.20 M(-3.3%) |
| Sept 2019 | - | $428.36 M(+2.7%) |
| June 2019 | - | $417.20 M(-17.5%) |
| Mar 2019 | - | $505.50 M(+16.0%) |
| Dec 2018 | $1.38 B(+71.3%) | $435.89 M(+9.4%) |
| Sept 2018 | - | $398.62 M(+15.2%) |
| June 2018 | - | $345.88 M(+69.1%) |
| Mar 2018 | - | $204.50 M(-4.9%) |
| Dec 2017 | $808.46 M(+8.6%) | $215.15 M(+10.2%) |
| Sept 2017 | - | $195.18 M(-9.3%) |
| June 2017 | - | $215.19 M |
| Dec 2016 | $744.27 M | - |
FAQ
- What is Amneal Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual total expenses year-on-year change?
- What is Amneal Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly total expenses year-on-year change?
What is Amneal Pharmaceuticals annual total expenses?
The current annual total expenses of AMRX is $2.17 B
What is the all time high annual total expenses for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual total expenses is $2.17 B
What is Amneal Pharmaceuticals annual total expenses year-on-year change?
Over the past year, AMRX annual total expenses has changed by +$145.97 M (+7.21%)
What is Amneal Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of AMRX is $625.99 M
What is the all time high quarterly total expenses for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly total expenses is $625.99 M
What is Amneal Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, AMRX quarterly total expenses has changed by +$82.47 M (+15.17%)